Cancer Therapy News and Research

RSS

Researchers design microfluidic platform to see how cancer cells invade specific organs

Nearly 70 percent of patients with advanced breast cancer experience skeletal metastasis, in which cancer cells migrate from a primary tumor into bone - a painful development that can cause fractures and spinal compression.

7 Feb 2014

Chemotherapy following radiation therapy improves survival for adults with brain tumor

Adults with low-grade gliomas, a form of brain tumor, who received a chemotherapy regimen following completion of radiation therapy, lived longer than patients who received radiation therapy alone, according to long-term follow-up results from a National Institutes of Health-supported randomized controlled clinical trial.

6 Feb 2014

Researchers discover genetic function that helps "tumor suppressor" genes to prevent cancer

Researchers at Oregon State University have discovered a genetic function that helps one of the most important "tumor suppressor" genes to do its job and prevent cancer.

4 Feb 2014

Researchers identify protein critical to hematopoietic stem cell function, blood formation

Researchers at the University of California, San Diego School of Medicine have identified a protein critical to hematopoietic stem cell function and blood formation. The finding has potential as a new target for treating leukemia because cancer stem cells rely upon the same protein to regulate and sustain their growth.

3 Feb 2014

New American Cancer Society report calls diagnosis of childhood cancer

A new report from the American Cancer Society outlines progress made and -more importantly-challenges that remain in fighting childhood cancer. The report estimates the number of new cancer cases and deaths for children and adolescents in the United States, summarizes the most recent and comprehensive data on cancer incidence, mortality, and survival, and outlines what is known and where answers are still needed for childhood cancers.

31 Jan 2014

Myriad Genetics' Prolaris opens door to a new era of personalized treatment for prostate cancer

Myriad Genetics, Inc. today announced results from PROCEDE 500, a clinical utility study with its Prolaris test, at the 2014 ASCO Genitourinary Cancers Symposium in San Francisco, Calif. The study demonstrated the significant clinical value of Prolaris to physicians who are treating men with prostate cancer. Prolaris is a prognostic test that accurately predicts prostate cancer-specific death and metastases and has been validated in 11 clinical studies with more than 5,000 patients.

29 Jan 2014

UNC researchers develop new radiation-free ultrasound technique to detect, monitor cancer

While ultrasound provides a less expensive and radiation-free alternative to detecting and monitoring cancer compared to technologies such as X-rays, CT scans, and MRIs, ultrasound has seen limited use in cancer treatment due to clarity and resolution issues.

29 Jan 2014

Music therapy interventions may provide essential psychosocial support to young patients with cancer

A new study has found that adolescents and young adults undergoing cancer treatment gain coping skills and resilience-related outcomes when they participate in a therapeutic music process that includes writing song lyrics and producing videos.

27 Jan 2014

Landmark study reveals positive effects of music therapy among youth undergoing cancer treatment

A ground-breaking collaborative multi-site study found that teens and young adults undergoing the rigors of stem cell transplantation as part of cancer treatment gain coping skills and resilience-related outcomes when participating with a board certified music therapist in a therapeutic music protocol that includes writing song lyrics and producing videos. s.

27 Jan 2014

Researchers examine effects of ACA on cancer survivors

In 2010, the total cost of cancer care in the United States reached $125 billion. Globally, the economic toll from cancer is nearly 20 percent higher than the leading cause of death, heart disease. Cancer patients are also living longer today, which is further increasing the cost of their continued care.

24 Jan 2014

Scientists develop mathematical model to predict tumor behavior and personalized therapies

Dana-Farber Cancer Institute scientists have developed a mathematical model to predict how a patient's tumor is likely to behave and which of several possible treatments is most likely to be effective.

24 Jan 2014

Many internists feel ill-equipped to care for childhood cancer survivors

A recent study shows that many internists feel ill-equipped to care for adult patients who are childhood cancer survivors. Eugene Suh, MD, assistant professor in the division of Pediatric Hematology and Oncology at Loyola University Chicago Stritch School of Medicine, was the first author on the study that was conducted at the University of Chicago with Tara Henderson, MD, MPH.

23 Jan 2014

ICR, Nuevolution and CRT partner to identify novel drug candidates for cancer treatment

The Institute of Cancer Research, London, Cancer Research Technology, London and Nuevolution A/S, Copenhagen have entered into a drug discovery collaboration to identify novel lead candidates for cancer treatment.

23 Jan 2014

Chinese and American researchers introduce new approach to gene therapy

Resistance of tumor cells toward multiple cytostatic drugs is a serious problem in cancer treatment. In the journal Angewandte Chemie, a team of Chinese and American researchers has now introduced a new approach to gene therapy that could counter this problem: The gene that codes for resistance is “silenced” through the use of an ingenious nanocomplex.

22 Jan 2014

Mutation in bone cells may cause acute myeloid leukemia: Study

Acute myeloid leukemia is a blood cancer, but for many patients the cancer may originate from an unusual source: a mutation in their bone cells.

21 Jan 2014

First patient dosed in ADXS-HPV Phase 1/2 study for HPV-associated head and neck cancer

Advaxis, Inc., a leader in developing the next generation of cancer immunotherapies, announced that the first patient has been dosed in a Phase 1/2 "window of opportunity" study being conducted by the Icahn School of Medicine at Mount Sinai. Patients diagnosed with HPV-associated head and neck cancer will receive ADXS-HPV immunotherapy during the "window" of time between initial diagnosis and minimally invasive transoral robotic surgery to remove their tumors.

21 Jan 2014

Researchers identify molecular mechanism by which cocaine alters brain's reward circuits, causes addiction

Researchers from the Icahn School of Medicine at Mount Sinai have identified a new molecular mechanism by which cocaine alters the brain's reward circuits and causes addiction.

21 Jan 2014

Research roundup: Nursing home transitions; the impact of raising Medicare premiums; workers' views of job-based insurance

Each week, KHN compiles a selection of recently released health policy studies and briefs.

20 Jan 2014

New collaboration aims to push cancer diagnostics to the next level

A collaboration between National Cancer Centre Singapore and Clearbridge BioMedics, in partnership with the Pathology Department at Singapore General Hospital has resulted in the establishment of the region's first Circulating Tumour Cell Centre of Research Excellence. This new Centre facilitates the use of circulating tumour cells in clinical diagnostics, in order for new technologies to be applied by healthcare institutions.

19 Jan 2014

Researchers find new way to boost survival of pediatric patients suffering cardiac arrest

Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford have found a new way to boost the survival of pediatric patients whose hearts stop while they are hospitalized.

16 Jan 2014

Cancer Therapy News and Research

Researchers design microfluidic platform to see how cancer cells invade specific organs

Chemotherapy following radiation therapy improves survival for adults with brain tumor

Researchers discover genetic function that helps "tumor suppressor" genes to prevent cancer

Researchers identify protein critical to hematopoietic stem cell function, blood formation

New American Cancer Society report calls diagnosis of childhood cancer

Myriad Genetics' Prolaris opens door to a new era of personalized treatment for prostate cancer

UNC researchers develop new radiation-free ultrasound technique to detect, monitor cancer

Music therapy interventions may provide essential psychosocial support to young patients with cancer

Landmark study reveals positive effects of music therapy among youth undergoing cancer treatment

Researchers examine effects of ACA on cancer survivors

Scientists develop mathematical model to predict tumor behavior and personalized therapies

Many internists feel ill-equipped to care for childhood cancer survivors

ICR, Nuevolution and CRT partner to identify novel drug candidates for cancer treatment

Chinese and American researchers introduce new approach to gene therapy

Mutation in bone cells may cause acute myeloid leukemia: Study

First patient dosed in ADXS-HPV Phase 1/2 study for HPV-associated head and neck cancer

Researchers identify molecular mechanism by which cocaine alters brain's reward circuits, causes addiction

Research roundup: Nursing home transitions; the impact of raising Medicare premiums; workers' views of job-based insurance

New collaboration aims to push cancer diagnostics to the next level

Researchers find new way to boost survival of pediatric patients suffering cardiac arrest

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News